Post Exposure Prophylaxis News and Research

RSS
Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

NIH offers support for HIV care and prevention research in the southern United States

NIH offers support for HIV care and prevention research in the southern United States

Study provides new insights into how prions enter the brain

Study provides new insights into how prions enter the brain

New simulation approach predicts efficacy of HIV-prophylaxis medications

New simulation approach predicts efficacy of HIV-prophylaxis medications

WHO certifies elimination of mother-to-child HIV and syphilis transmission in six Caribbean territories

WHO certifies elimination of mother-to-child HIV and syphilis transmission in six Caribbean territories

New HIV prevention guidelines from Canada released

New HIV prevention guidelines from Canada released

HIV prevention drug to be trialed by Britain's NHS

HIV prevention drug to be trialed by Britain's NHS

Measles outbreak - 35 reported deaths in Europe

Measles outbreak - 35 reported deaths in Europe

Treatment with interferon may ease symptoms of Ebola patients

Treatment with interferon may ease symptoms of Ebola patients

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

New antibody-based therapy may provide better strategy for long-term control of HIV

New antibody-based therapy may provide better strategy for long-term control of HIV

Researchers use quick screening method to identify, test promising anti-Ebola drugs

Researchers use quick screening method to identify, test promising anti-Ebola drugs

New framework launched for global elimination of human rabies

New framework launched for global elimination of human rabies

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Bioethics Commission makes recommendations on preparedness for public health emergencies

Bioethics Commission makes recommendations on preparedness for public health emergencies

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

New guidelines integrate biomedical advances and behavioral interventions for HIV people

New guidelines integrate biomedical advances and behavioral interventions for HIV people

Emergent BioSolutions reports total revenue of $53.9 million for Q1 2014

Emergent BioSolutions reports total revenue of $53.9 million for Q1 2014

FDA grants Orphan Drug Designation to Emergent BioSolutions' BioThrax for PEP of anthrax disease

FDA grants Orphan Drug Designation to Emergent BioSolutions' BioThrax for PEP of anthrax disease